HPV-associated cancers in immune deficient populations
2009-09-09 - English

After viewing this presentation, the participant will be able to:
- Describe the range of HPV-associated cancers
- Recognise the range of cancers increased with immune deficiency
- Understand the relationship between reversal of immune deficiency and cancer risk

Effect of recombinant interleukin-2 (IL-2) on clinical outcomes in patients with CD4+ T-cell count 50 to 299/mm3: Primary results of the SILCAAT study
2009-09-09 - English

After viewing this presentation, the participant will be able to:
- Understand the purpose of this immunotherapy trial
- Understand the trial methodology behind a clinical end point study
- Understand the effects of recombinant interleukin-2 on CD4+ T-cell counts and clinical endpoints

Immunologic aging: Are antiretroviral treated patients aging too fast and if so why?
2009-09-10 - English

After viewing this presentation the participant will be able to discuss:
- Mechanisms of persistent inflammation in HIV-infected patients on therapy
- The relationship between residual inflammation and suboptimal CD4+ gains
- The relationship of these factors to non-AIDS events and premature mortality

Understanding HIV latency and strategies for HIV eradication
2009-09-10 - English

After viewing this presentation, the participant will be able to:
- Understand the barriers to HIV eradication
- Know the anatomical and cellular reservoirs for HIV in patients on suppressive HAART
- Understand the role of chemokine receptors in establishing HIV latency
- Understand the rationale for eradication strategies

Markers of inflammation, coagulation and renal function in HIV-infected adults in smart and in two large population-based studies, Cardia and Mesa
2009-09-10 - English

After viewing this presentation the participant will be able to discuss:
- The levels of four biomarkers (hsCRP, IL-6, D-dimer and cystatin-C) in patients with HIV compared to the general population
- The effects of HIV and antiretroviral therapy on these markers

Predicting the short term risk of diabetes in HIV infected patients: the D:A:D study group
2009-09-10 - English

After viewing this presentation the participant will be able to discuss:
- Components of the D:A:D DM prediction model for HIV infected populations
- Performance of this model compared to the Framingham DM prediction model
- Limitations of the D:A:D model

Predictors of initial episode bacterial Pneumonia in ESPRIT
2009-09-10 - English

After viewing this presentation, the participant will be able to:
- Identify risk factors associated with initial episode bacterial pneumonia in ESPRIT

A screening algorithm for HIV associated neurocognitive disorders
2009-09-10 - English

After viewing this presentation, the participant will be able to:
- Understand the validation steps of the Neurological Algorithm
- Understand how to use the Neurological Algorithm
- Provide more targeted care to HIV+ individuals at risk for cognitive impairment
- Understand the basis of HIV-associated neurocognitive impairment

High levels of user acceptability and cytological abnormalities in self collected anal swabs among HIV-infected men who have sex with men in Sydney
2009-09-10 - English

After viewing this presentation the participant will be able to discuss:
- Results from the Blokes with Anal Squamous Intraepithelial Lesions (BASIL) study
-The level of user acceptability for self collected anal cytology swabs
-The level of anal cytological abnormalities in a cohort of HIV+MSM in Sydney

The changing nature of antiretroviral treatment failure
2009-09-10 - English

After viewing this presentation the participant will be able to discuss:
- Highlights from the U.S. DHHS guidelines for the use of antiretroviral agents in HIV-1-infected adults and adolescents
- New data on switching therapies
- Deep salvage therapies
- Agents that promote CD4+ recovery

Cardiovascular Disease - How Should it Affect Antiretroviral Therapy?
2009-09-10 - English

After viewing this presentation, the participant will be able to:
- Understand the epidemiology of cardiovascular disease in HIV-infected adults
- Understand the role of surrogate markers in predicting cardiovascular risk in HIV-infected adults
- Understand the evidence underlying current recommendations in the Australian antiretroviral guidelines pertaining to cardiovascular disease

Immune-based therapies for HIV infection: where might this be heading now?
2009-09-11 - English

After viewing this presentation, the participant will be able to:
- Identify recent developments in immune-based therapeutics for HIV disease
- Address the fundamental challenges with this approach to treatment
- Identify niche areas where immune based therapies might have utility

Immune Responses in Co-infection
2009-09-11 - English

After viewing this presentation, the participant will be able to:
- Understand the scope of coinfection in persons infected with HIV, the complexity of the interaction and the limitation of currently available studies’ results
- Understand the key concepts of immune...(more)

Practical issues in prescribing antiretrovirals in pregnancy and in women who may become pregnant
2009-09-11 - English

After viewing this presentation, the participant will be able to:
- Understand the components of pre-pregnancy counselling and their relevance to antiretroviral prescribing
- Understand the difference between recommended first line antiretrovirals in adults compared with...(more)

Qualitative features of an effective immune response to HIV
2009-09-11 - English

After viewing this presentation, the participant will be able to:
- Understand the prevalence and demographics of patients with durable control of HIV
- Understand the possible host or viral factors involved in immunologic control of HIV
- Discuss our current understanding of how the CD8+ T cell response likely mediates immunologic control and the ramifications for vaccines for HIV